In a post‑gastric sleeve patient taking iron‑containing supplements who has had ferritin levels in the 400 µg/L range for a year with normal liver enzymes, what could be causing the elevated ferritin?

Elevated Ferritin in Post-Gastric Sleeve Patient Taking Iron Supplements

In a post-gastric sleeve patient with ferritin in the 400s and normal liver enzymes, the elevated ferritin is most likely due to iron supplementation triggering hepcidin-mediated iron sequestration rather than true iron overload, particularly given the normal liver enzymes.

Understanding the Mechanism

The key to understanding this scenario lies in recognizing that ferritin elevation does not always indicate iron overload—especially in the context of bariatric surgery. According to the AASLD hemochromatosis guidelines, ferritin has a significant false positive rate because it is an acute-phase reactant that can be elevated in the absence of increased iron stores 1.

Post-Bariatric Surgery Iron Metabolism

Recent research has revealed a critical mechanism specific to post-gastric sleeve patients 2:

• Hepcidin dysregulation: After vertical sleeve gastrectomy, oral iron supplementation triggers a disproportionate rise in hepatic hepcidin
• Iron sequestration: Elevated hepcidin causes ferroportin degradation, trapping absorbed iron within enterocytes, hepatocytes, and macrophages
• Paradoxical deficiency: This creates a situation where ferritin appears elevated (reflecting sequestered iron) while functional iron availability remains inadequate

This explains why ferritin levels of 400 µg/L can persist despite normal liver enzymes—the iron is sequestered rather than causing tissue damage.

Differential Diagnosis Framework

Most Likely Causes (in order of probability):

1. Iron supplement-induced hepcidin elevation with sequestration 2

   • Ferritin 400s with normal liver enzymes fits this pattern
   • Iron is trapped in storage sites rather than causing overload

2. Metabolic dysfunction-associated steatotic liver disease (MASLD) 3

   • Common in post-bariatric patients with insulin resistance
   • Can cause hyperferritinemia (even >1000 µg/L) with normal transferrin saturation
   • Reflects inflammatory signaling rather than iron overload

3. Chronic low-grade inflammation 4

   • Ferritin as acute-phase reactant
   • Check CRP to assess inflammatory state

Less Likely (but must exclude):

1. True iron overload/hemochromatosis
   • Would typically show elevated transferrin saturation (≥45%) 1
   • Ferritin <1000 µg/L with normal liver enzymes predicts absence of cirrhosis 1

Diagnostic Algorithm

Step 1: Measure Transferrin Saturation

• If TS <45%: Iron overload is unlikely; ferritin elevation is non-specific 1
• If TS ≥45%: Consider HFE genetic testing for hemochromatosis 1

Step 2: Assess Inflammatory Status

• Check CRP or ESR 4
• If inflammation present: Ferritin >100 µg/L can occur without iron deficiency 4
• If no inflammation: Ferritin more reliably reflects iron stores

Step 3: Evaluate Metabolic Factors

Look for features of MASLD 3:

• Insulin resistance (HOMA-IR, fasting glucose/insulin)
• Hypertriglyceridemia
• Hepatic steatosis on imaging
• Polyclonal hypergammaglobulinemia (if available)

Step 4: Consider MRI Liver Iron Quantification

Only if transferrin saturation is elevated or clinical suspicion for true iron overload exists 3, 5:

• Normal liver iron concentration (<3 mg/g) definitively excludes iron overload
• Avoids unnecessary phlebotomy or invasive procedures

Management Approach

Immediate Actions:

1. Stop or reduce iron supplementation temporarily 2

   • The iron supplements may be driving hepcidin elevation
   • Monitor ferritin response over 2-3 months

2. Check complete iron panel:

   • Serum iron
   • Total iron binding capacity (TIBC)
   • Transferrin saturation
   • Hemoglobin/hematocrit

3. Assess for anemia:

   • If anemic despite elevated ferritin, this confirms functional iron deficiency 2
   • Hepcidin is sequestering iron despite supplementation

If Functional Iron Deficiency Confirmed:

Consider hepcidin-suppressive strategies 2:

• Curcumin supplementation has shown promise in restoring ferroportin and mobilizing sequestered iron
• Intravenous iron may bypass the hepcidin-mediated enterocyte block 6
• Alternate-day oral iron dosing (rather than daily) may reduce hepcidin surge 6

If No Iron Deficiency:

• Discontinue iron supplements 6
• Iron supplementation with normal/high ferritin is not recommended and potentially harmful
• Monitor ferritin every 6-12 months
• Address underlying metabolic factors (weight management, insulin resistance)

Critical Pitfalls to Avoid

1. Do not assume elevated ferritin = iron overload in post-bariatric patients 1, 3

   • Normal liver enzymes argue strongly against tissue iron deposition
   • Transferrin saturation is the key discriminator

2. Do not initiate phlebotomy without confirming true iron overload 5

   • Requires either elevated TS or MRI-confirmed elevated liver iron concentration
   • Inappropriate phlebotomy can worsen functional iron deficiency

3. Do not continue iron supplementation indefinitely without reassessment 6, 2

   • May perpetuate hepcidin-mediated sequestration
   • Can lead to genuine iron overload over time

4. Do not ignore metabolic syndrome features 3

   • MASLD is increasingly common post-bariatric surgery
   • Hyperferritinemia may reflect immunometabolic dysfunction

Bottom Line

In this post-gastric sleeve patient, ferritin of 400 µg/L with normal liver enzymes most likely represents iron supplement-induced hepcidin elevation with sequestration or MASLD-related inflammation, not true iron overload. Measure transferrin saturation to confirm—if <45%, reassure the patient, stop iron supplements, and monitor. Only pursue iron overload workup if TS is elevated 1, 2, 3.